Effects of guided imagery on anxiety, muscle pain and vial signs in patients with COVID-19

Not Applicable

Conditions: COVID-19.
COVID-19, virus identified
U07.1

Registration Number: IRCT20131112015390N5

Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 110

Inclusion Criteria

The sample should be positive for covid-19 with PCR test.
Be between 18 and 60 years old.
Allow the treating physician to intervene.
The sample must be alert and oriented.
Be able to speak Persian.
Willingness to participate in the study with complete satisfaction.

Exclusion Criteria

The sample have a history of mental illness and a previous history of Covid-19.
SPO2% < 93%

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety Scale in Spielberger's Hidden and Obvious Anxiety Scale Questionnaire. Timepoint: Measuring anxiety in the first session (before the intervention) and then After completing the guided mental imagery training sessions on the fifth day. Method of measurement: Spielberger's Hidden and Obvious Anxiety Scale Questionnaire.;Pain Quality Score on the McGill Pain Questionnaire. Timepoint: Measuring quality of pain in the first session (before the intervention) and then After completing the guided mental imagery training sessions on the fifth day. Method of measurement: McGill Pain Questionnaire.;Pain intensity score on the Visual Analog Scale. Timepoint: Measuring pain intensity in the first session (before the intervention) and then After completing the guided mental imagery training sessions on the fifth day. Method of measurement: Visual Analog Scale.

Secondary Outcome Measures